Anatol Kreitzer
Chief Discovery Officer, MapLight Therapeutics, Inc.
Bought, 12 months
$0.0M
Sold, 12 months
$2.9M
Companies
1
Latest trade
Oct 15, 2026
Companies
MapLight Therapeutics, Inc.Chief Discovery Officer −$2.9MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.
